Cover Image
市場調查報告書

髓核置換的全球市場:醫療設備的開發平台評估

Nucleus Replacement - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 358893
出版日期 內容資訊 英文 63 Pages
訂單完成後即時交付
價格
Back to Top
髓核置換的全球市場:醫療設備的開發平台評估 Nucleus Replacement - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年06月14日 內容資訊: 英文 63 Pages
簡介

本報告提供全球髓核置換市場上的主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,再加上產品的功能·特性比較分析 (臨床實驗的進展各階段) ,再彙整主要企業簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 髓核置換概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 髓核置換的企業:各臨床實驗階段的開發中產品
  • 髓核置換:各臨床實驗階段的開發中產品

第5章 髓核置換市場:企業·產品概要

  • Arthro Kinetics AG
    • 開發中產品及進行中的臨床實驗概要
  • Chi2Gel Ltd.
  • Clariance SAS
  • CryoLife, Inc.
  • Gentis Inc.
  • Hydrospine, Inc.
  • Raymedica, LLC
  • Replication Medical, Inc.
  • Spinalcyte Llc
  • Spine Wave, Inc.
  • Stryker Corporation
  • Synthes, Inc.
  • TranS1 Inc
  • Vertebral Technologies, Inc.
  • Zimmer Biomet Holdings, Inc.

第6章 髓核置換市場:目前的趨勢 (全4件)

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's Medical Devices sector report, "Nucleus Replacement - Medical Devices Pipeline Assessment, 2017" provides an overview of Nucleus Replacement currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Nucleus Replacement pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Nucleus Replacement under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Nucleus Replacement and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Nucleus Replacement under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 Nucleus Replacement Overview 6

3 Products under Development 7

  • 3.1 Nucleus Replacement - Pipeline Products by Stage of Development 7
  • 3.2 Nucleus Replacement - Pipeline Products by Territory 8
  • 3.3 Nucleus Replacement - Pipeline Products by Regulatory Path 9
  • 3.4 Nucleus Replacement - Pipeline Products by Estimated Approval Date 10
  • 3.5 Nucleus Replacement - Ongoing Clinical Trials 11

4 Nucleus Replacement - Pipeline Products under Development by Companies 12

  • 4.1 Nucleus Replacement Companies - Pipeline Products by Stage of Development 12
  • 4.2 Nucleus Replacement - Pipeline Products by Stage of Development 13

5 Nucleus Replacement Companies and Product Overview 14

  • 5.1 Arthro Kinetics AG Company Overview 14
    • 5.1.1 Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 14
  • 5.2 Chi2Gel Ltd. Company Overview 15
    • 5.2.1 Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.3 Clariance Inc Company Overview 16
    • 5.3.1 Clariance Inc Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.4 CryoLife Inc Company Overview 17
    • 5.4.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.5 DePuy Synthes Inc Company Overview 18
    • 5.5.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.6 Gentis Inc Company Overview 19
    • 5.6.1 Gentis Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.7 Hydrospine, Inc. Company Overview 20
    • 5.7.1 Hydrospine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.8 Ortho Regenerative Technologies Inc Company Overview 21
    • 5.8.1 Ortho Regenerative Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.9 Raymedica, LLC Company Overview 22
    • 5.9.1 Raymedica, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.10 Replication Medical Inc Company Overview 23
    • 5.10.1 Replication Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.11 Spine Wave Inc Company Overview 24
    • 5.11.1 Spine Wave Inc Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.12 Stryker Corporation Company Overview 26
    • 5.12.1 Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.13 TranS1 Inc Company Overview 27
    • 5.13.1 TranS1 Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.14 Vertebral Technologies Inc Company Overview 28
    • 5.14.1 Vertebral Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.15 Zimmer Biomet Holdings Inc Company Overview 31
    • 5.15.1 Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 31

6 Nucleus Replacement- Recent Developments 33

  • 6.1 Apr 27, 2017: SpinalCyte Receives New Australian Patent 33
  • 6.2 Apr 27, 2017: Zimmer Biomet Reports First Quarter 2017 Financial Results 33
  • 6.3 Apr 27, 2017: RTI Surgical Announces 2017 First Quarter Results 34
  • 6.4 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results 35
  • 6.5 Apr 25, 2017: Stryker reports first quarter 2017 results 36
  • 6.6 Apr 12, 2017: Brian May Joins Spine Wave as Executive Vice President, Research and Development 37
  • 6.7 Apr 06, 2017: SpinalCyte Receives New European Patent 37
  • 6.8 Feb 23, 2017: RTI Surgical Announces 2016 Fourth Quarter, Full Year Results; Initiates Actions to Improve Execution and Return to Profitable Growth 38
  • 6.9 Feb 15, 2017: CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results 40
  • 6.10 Feb 09, 2017: SpinalCyte Announces New U.S. Patent 41
  • 6.11 Jan 31, 2017: Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results 41
  • 6.12 Jan 26, 2017: RTI Surgical Names Camille Farhat Chief Executive Officer 42
  • 6.13 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 43
  • 6.14 Jan 17, 2017: Zimmer Biomet Announces Americas Leadership Transition 45
  • 6.15 Jan 17, 2017: RTI Surgical Extends Deadline for Nominating Directors to the Board 45
  • 6.16 Jan 12, 2017: Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters 45
  • 6.17 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 46
  • 6.18 Jan 10, 2017: Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results 47
  • 6.19 Dec 14, 2016: RTI Surgical Names Robert P. Jordheim Interim CEO 48
  • 6.20 Dec 14, 2016: Zimmer Biomet Update on Product Supply Matters and Responsive Statement on Recently Completed FDA Inspection 48
  • 6.21 Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results 49
  • 6.22 Oct 27, 2016: Stryker reports third quarter 2016 results 50
  • 6.23 Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results 51
  • 6.24 Oct 25, 2016: RTI Surgical Announces 2016 Third Quarter Results 52
  • 6.25 Oct 25, 2016: James W. Bullock Joins CryoLife Board of Directors 53
  • 6.26 Sep 06, 2016: CryoLife Appoints James McDermid as Chief Human Resources Officer 54
  • 6.27 Aug 15, 2016: RTI Surgical Announces CEO Brian Hutchison to Retire 54
  • 6.28 Jul 28, 2016: Zimmer Biomet Reports Second Quarter 2016 Financial Results 55
  • 6.29 Jul 27, 2016: RTI Surgical Announces 2016 Second Quarter Results 55
  • 6.30 Jul 25, 2016: CryoLife Reports Second Quarter 2016 Financial Results 57
  • 6.31 Jul 21, 2016: Stryker reports second quarter 2016 results 58

7 Appendix 60

  • 7.1 Methodology 60
  • 7.2 About GlobalData 63
  • 7.3 Contact Us 63
  • 7.4 Disclaimer 63

List of Tables

1.1 List of Tables

  • Table 1: Nucleus Replacement - Pipeline Products by Stage of Development 7
  • Table 2: Nucleus Replacement - Pipeline Products by Territory 8
  • Table 3: Nucleus Replacement - Pipeline Products by Regulatory Path 9
  • Table 4: Nucleus Replacement - Pipeline Products by Estimated Approval Date 10
  • Table 5: Nucleus Replacement - Ongoing Clinical Trials 11
  • Table 6: Nucleus Replacement Companies - Pipeline Products by Stage of Development 12
  • Table 7: Nucleus Replacement - Pipeline Products by Stage of Development 13
  • Table 8: Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 14
  • Table 9: NuReS - Product Status 14
  • Table 10: NuReS - Product Description 14
  • Table 11: Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 12: Chi2Disc - Product Status 15
  • Table 13: Chi2Disc - Product Description 15
  • Table 14: Clariance Inc Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 15: NucleoFill - Product Status 16
  • Table 16: NucleoFill - Product Description 16
  • Table 17: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 18: Biodisc Nucleus Pulposus Replacement - Product Status 17
  • Table 19: Biodisc Nucleus Pulposus Replacement - Product Description 17
  • Table 20: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 21: Hydrafil - Product Status 18
  • Table 22: Hydrafil - Product Description 18
  • Table 23: Gentis Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 24: DiscCell - Product Status 19
  • Table 25: DiscCell - Product Description 19
  • Table 26: Hydrospine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 27: Intervertebral Disc Repair System - Product Status 20
  • Table 28: Intervertebral Disc Repair System - Product Description 20
  • Table 29: Ortho Regenerative Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 30: Nucleus Pulposus Repair Device - Product Status 21
  • Table 31: Nucleus Pulposus Repair Device - Product Description 21
  • Table 32: Raymedica, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 33: HydraFlex Nucleus Arthroplasty System - Product Status 22
  • Table 34: HydraFlex Nucleus Arthroplasty System - Product Description 22
  • Table 35: Replication Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 36: NeuDisc - Product Status 23
  • Table 37: NeuDisc - Product Description 23
  • Table 38: Spine Wave Inc Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 39: NuCore Injectable Nucleus - Product Status 24
  • Table 40: NuCore Injectable Nucleus - Product Description 24
  • Table 41: NuCore RPXL Injectable Nucleus - Product Status 25
  • Table 42: NuCore RPXL Injectable Nucleus - Product Description 25
  • Table 43: Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 44: Aquarelle - Product Status 26
  • Table 45: Aquarelle - Product Description 26
  • Table 46: TranS1 Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 47: Percutaneous Nucleus Replacement - Product Status 27
  • Table 48: Percutaneous Nucleus Replacement - Product Description 27
  • Table 49: Vertebral Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 50: InterCushion Disc Nucleus Replacement System - Product Status 28
  • Table 51: InterCushion Disc Nucleus Replacement System - Product Description 28
  • Table 52: Vertebral Technologies Inc - Ongoing Clinical Trials Overview 29
  • Table 53: InterCushion Disc Nucleus Replacement System - A Pilot Clinical Study to Assess the Safety and Effectiveness of the InterCushion Disc Nucleus Prosthesis in Patients Receiving Discectomy 30
  • Table 54: Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 55: Newcleus - Product Status 31
  • Table 56: Newcleus - Product Description 31
  • Table 57: Regain Lumbar Artificial Disc - Product Status 32
  • Table 58: Regain Lumbar Artificial Disc - Product Description 32
  • Table 59: Glossary 62

List of Figures

1.2 List of Figures

  • Figure 1: Nucleus Replacement - Pipeline Products by Stage of Development 7
  • Figure 2: Nucleus Replacement - Pipeline Products by Territory 8
  • Figure 3: Nucleus Replacement - Pipeline Products by Regulatory Path 9
  • Figure 4: Nucleus Repla
Back to Top